• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Terns Pharmaceuticals Inc (NQ: TERN )

    8.475 -0.535 (-5.94%)
    Streaming Delayed Price Updated: 3:50 PM EDT, Jul 29, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Terns Pharmaceuticals Inc

    < Previous 1 2 3 Next >
    Terns Pharmaceuticals Appoints Biotech Executive Elona Kogan as Chief Legal Officer and Announces Upcoming CFO Transition
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
    TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting in greater weight loss, increased fat mass loss and relative preservation of lean... 
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in UBS Obesity Therapeutics Day
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Leadership Changes
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference 2024
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Data from Ongoing Phase 1 Pharmacokinetic Study of Allosteric BCR-ABL Inhibitor TERN-701 in Adult Healthy Volunteers and Highlights Potential for Competitive Differentiation
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Melita Sun Jung as Chief Business Officer
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Orphan Drug Designation Granted to TERN-701 for the Treatment of Chronic Myeloid Leukemia
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Chief Executive Officer Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Appoints Amy Burroughs as Chief Executive Officer
    Proven Industry Executive Brings More Than 25 Years of Leadership Experience 
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Highlight 2024 Priorities and Clinical Milestones at the 42nd Annual J.P. Morgan Healthcare Conference
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Present at the JMP Securities Hematology and Oncology Summit
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Mourns the Loss of Senthil Sundaram, Former Chief Executive Officer
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Updates
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Presents Late-Breaking Data from Phase 2a DUET Trial of THR-β Agonist TERN-501 in NASH at AASLD The Liver Meeting® 2023
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in Upcoming November Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces First Participant Dosed in Phase 1 Clinical Trial of TERN-601 Oral GLP-1 Receptor Agonist for Treatment of Obesity
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Announces Global Phase 1 Clinical Trial Design of TERN-701 for the Treatment of Chronic Myeloid Leukemia
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
    From Terns Pharmaceuticals, Inc.
    Via GlobeNewswire
    < Previous 1 2 3 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.